This content is machine translated Migraine Fremanezumab for comorbid migraine and depression Migraine and depression often reinforce each other and make treatment more difficult. The UNITE study shows that the CGRP antibody fremanezumab significantly reduces both migraine days and depressive symptoms –...…
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14–15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 6 min This content is machine translated Migraine prophylaxis with medication Keeping an eye on comorbidities The market approval of CGRP antibodies has revolutionized the treatment options for migraine. It is a therapy option that is very popular with patients and whose efficacyis supported by a…
View Post 4 min This content is machine translated Pain Medicine Effective and modern care for migraine and co. This year’s Pain and Palliative Day was held under the motto “Worry and care – pain medicine in practice”. In addition to health services research, discussion panels will focus on…
